DAWN SIMS: Open Payments
NPI 1174912299 · FRIENDSWOOD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$866 in 20 payments from 8 companies in 2025. Trend: 2023 $268 · 2024 $869 · 2025 $866
Food & beverage: $866
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $198 |
| Otsuka America Pharmaceutical, Inc. | 3 | $171 |
| Axsome Therapeutics, Inc. | 5 | $169 |
| Teva Pharmaceuticals USA, Inc. | 1 | $116 |
| ABBVIE INC. | 2 | $101 |
| Janssen Pharmaceuticals, Inc | 1 | $69 |
| Lundbeck LLC | 1 | $22 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
Products named: CAPLYTA, REXULTI, Auvelity, AUSTEDO XR, VRAYLAR, INVEGA SUSTENNA, INGREZZA.
Industry payments across TX — which companies pay providers there.
